Recurrence of Primary Headache Disorders After Emergency Department Discharge: Frequency and Predictors of Poor Pain and Functional Outcomes

被引:35
作者
Friedman, Benjamin W. [1 ]
Hochberg, Michael L.
Esses, David
Grosberg, Brian M.
Rothberg, Daniel
Bernstein, Benjamin
Bijur, Polly E.
Lipton, Richard B.
Gallagher, E. John
机构
[1] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Emergency Med, Bronx, NY 10467 USA
关键词
D O I
10.1016/j.annemergmed.2008.01.334
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
Study objective: We determine the frequency of moderate or severe headache during the first 24 hours after an emergency department (ED) visit for a primary headache disorder (such as migraine or tension-type headache), determine the burden of headache during the 3 months after the ED visit, and identify predictors of poor pain and functional outcomes after ED discharge for each of these periods. Methods: In this prospective cohort study, we enrolled headache patients during their initial ED visit, interviewed them by using a standardized questionnaire, and followed them by telephone 24 hours and 3 months after ED discharge. Two emergency physicians classified all headaches according to criteria established by the International Headache Society, using a valid questionnaire and a reproducible technique. Results: During an 18-month period, we enrolled 309 primary headache disorder patients in the cohort. The most common primary headache diagnoses assigned to patients were migraine, tension-type headache, and unclassifiable recurrent headache disorder. We successfully obtained follow-up in 94% of patients 24 hours after ED discharge and in 94% 3 months after ED discharge. Moderate or severe headache was present within 24 hours of ED discharge in 31% (95% confidence interval [CI] 25% to 38%) of migraine patients, 19% (95% CI 9% to 36%) of tension-type headache patients, and 27% (95% CI 18% to 38%) of the unclassifiable headache patients. Multiple functionally impairing headaches occurred during the 3 months after ED discharge in 37% of migraine patients (95% CI 30% to 44%), 38% of tension-type headache patients (95% CI 23% to 54%), and 26% of the unclassifiable headache patients (95% CI 17% to 37). After multivariate adjustment, independent predictors of poor 24-hour outcomes were severe baseline pain, baseline nausea, screening positive for depression, and longer duration of headache; the independent predictor of poor 3-month outcomes was Medicaid insurance. Conclusion: Regardless of type of primary headache disorder, ED headache patients frequently experience pain and functional impairment during the hours and months after discharge. [Ann Emerg Med. 2008;52:696-704.]
引用
收藏
页码:696 / 704
页数:9
相关论文
共 47 条
[1]
SUBCUTANEOUS SUMATRIPTAN FOR TREATMENT OF ACUTE MIGRAINE IN PATIENTS ADMITTED TO THE EMERGENCY DEPARTMENT - A MULTICENTER STUDY [J].
AKPUNONU, BE ;
MUTGI, AB ;
FEDERMAN, DJ ;
VOLINSKY, FG ;
BRICKMAN, K ;
DAVIS, RI ;
GILBERT, C ;
ASGHARNEJAD, M .
ANNALS OF EMERGENCY MEDICINE, 1995, 25 (04) :464-469
[2]
Bigal M, 2000, Sao Paulo Med J, V118, P58
[3]
Intravenous Chlorpromazine in the Emergency Department treatment of migraines: A randomized controlled trial [J].
Bigal, ME ;
Bordini, CA ;
Speciali, JG .
JOURNAL OF EMERGENCY MEDICINE, 2002, 23 (02) :141-148
[4]
Intravenous chlorpromazine in the acute treatment of episodic tension-type headache - A randomized, placebo controlled, double-blind study [J].
Bigal, ME ;
Bordini, CA ;
Speciali, JG .
ARQUIVOS DE NEURO-PSIQUIATRIA, 2002, 60 (3A) :537-541
[5]
Defeating migraine pain with triptans: A race against the development of cutaneous allodynia [J].
Burstein, R ;
Collins, B ;
Jakubowski, M .
ANNALS OF NEUROLOGY, 2004, 55 (01) :19-26
[6]
Tbe development of cutaneous allodynia during a migraine attack - Clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine [J].
Burstein, R ;
Cutrer, MF ;
Yarnitsky, D .
BRAIN, 2000, 123 :1703-1709
[7]
INTRAVENOUS CHLORPROMAZINE VS INTRAVENOUS METOCLOPRAMIDE IN ACUTE MIGRAINE HEADACHE [J].
CAMERON, JD ;
LANE, PL ;
SPEECHLEY, M .
ACADEMIC EMERGENCY MEDICINE, 1995, 2 (07) :597-602
[8]
Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache [J].
Carleton, SC ;
Shesser, RF ;
Pietrzak, MP ;
Chudnofsky, CR ;
Starkman, S ;
Morris, DL ;
Johnson, G ;
Rhee, KJ ;
Barton, CW ;
Chelly, JE ;
Rosenberg, J ;
Van Valen, MK .
ANNALS OF EMERGENCY MEDICINE, 1998, 32 (02) :129-138
[9]
A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department [J].
Cete, Y ;
Dora, B ;
Ertan, C ;
Ozdemir, C ;
Oktay, C .
CEPHALALGIA, 2005, 25 (03) :199-204
[10]
Reliability and validity of the Migraine Therapy Assessment Questionnaire [J].
Chatterton, ML ;
Lofland, JH ;
Shechter, A ;
Curtice, WS ;
Hu, XH ;
Lenow, J ;
Smullens, SN ;
Nash, DB ;
Silberstein, SD .
HEADACHE, 2002, 42 (10) :1006-1015